Experience the forefront of pharmaceutical innovation as Labroots and the Drug Discovery and Development planning committee host the 8th Annual Event in the Drug Discovery & Development Virtual Event Series on February 19th, 2025. Join industry and academic leaders to explore the latest breakthroughs, challenges, and successes in this ever-evolving field.
The 2025 program covers a wide range of tracks and topics, including Emerging Modalities in Drug Discovery and Preclinical Development covering microphysiological systems, emerging assays, and ADCs. In the Laboratory QA/QC track our expert speakers dive into the 3Rs, in-vitro models of toxicity, and predicting safety and efficacy. Finally, our speakers elucidate the complexities of this broad and evolving field with a track dedicated to Advancing the Art: Improving Drug Discovery Methodology.
Mark your calendars and join us for a full day of innovation and knowledge sharing at this transformative virtual event!
Emerging Modalities in Drug Discovery and Preclinical Development
Laboratory QA/QC
Advancing the Art: Improving Drug Discovery Methodology
Call for Posters — Virtual poster sessions offer the opportunity to present data to a global audience via a PDF poster and video summary, and discuss results with interested colleagues through email. Plan now to have your poster included in the 2025 Drug Discovery & Development Virtual Event. Submission is free. Submit your abstract here.
Our virtual conference allows you to participate in a global setting with no travel or cost to you. The event will remain open for 1 year from the date of the live event, and the webinars will be available for unlimited on-demand viewing. This virtual conference also offers increased reach for the global drug discovery community with a high degree of interaction through live-streaming video and chat sessions.
Connect with us!
When you attend the event remember to use the hashtag #LRdrug to follow the conversation and connect with other members of the global Drug Discovery & Development community! Follow @DrugDiscoveryLR on Twitter and @DrugDiscoveryandDevelopment on Facebook to connect with our specialist Drug Discovery & Development writers and stay up to date with the latest Trending News in Drug Discovery & Development.
You can now also join our Drug Discovery, Development, & Therapeutics professional networking group on LinkedIn!
Labroots is a proud partner of Chati, a virtual event platform that allows for the hosting of engaging and interactive virtual and hybrid events, catering to businesses of any vertical or size.
Continuing Education
Labroots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this event, you can earn 1 Continuing Education credit per presentation for a maximum of 30 credits.
Professor, Feik School of Pharmacy, University of the Incarnate Word
Professor of Pharmacology (Tenured), College of Pharmacy, Professor of Biomedical Sciences, College of Graduate Studies, Midwestern University, Glendale
PHC Corporation of North America (PHCNA) is headquartered in Wood Dale, IL and manufactures and markets PHCbi brand laboratory equipment. PHCNA is a subsidiary of PHC Holdings Corporation of Tokyo, Japan, a global diversified life sciences, diagnostics, and medical device ...
See more